We are the site-side partner for biopharmaceutical companies developing and launching interventional psychiatric medicines. The same engine that runs your protocols today prepares your sites to deliver your medicine after approval.
Sites run the trial. Sites administer the medicine after approval. The clinical work, the patient relationships, and the operational rigor all live there.
But your reach into the site is narrow. CROs operate on your side. They do not own site success. MSLs are limited to non-promotional, scientific exchange.
BSS fills the gap. We are independent, site-side, operationally accountable. We build sites that run your protocols today and deliver your medicine tomorrow.
Site-side expertise turns community practices into the sites sponsors come back to. We hold the site through activation, first patient, and steady state, in regions and populations the academic medical center pathway does not reach.
We stand up community psychiatric practices as research-ready sites: training, SOPs, regulatory, DEA, electronic systems.
Controlled-substance compliance, AE protocols, expectancy and unblinding management, longitudinal monitoring.
Senior CRC and research-manager roles through activation, first patient, and steady state, until the site can run on its own.
The same operational engine, applied to launch readiness. Ready to build DEA-licensed, REMS-ready sites, literate in your modality.
Site preparation for new-modality launch: facility setup, REMS-style documentation, treatment-space setup, staff training, first-patient support.
Independent, label-aligned, CME/CE-accredited education on the clinical nuance that determines safe, appropriate use.
Aggregated de-identified operational and post-approval signals from a distributed prescriber base, surfaced under appropriate firewalls.
A growing network of capable community practices, distributed across the US. Prepared for your protocols today, prepared for your medicine after approval.
Bring us a protocol, a region, or a launch readiness question.